By interacting with nearly all systems involved in gut-brain communication, reduced levels of butyrate can likely be linked to AD processes by affecting synaptic plasticity, amyloid-beta and tau pathologies, and neuroinflammation (Qian et al., 2022). Here, MAPT is linked to Alzheimer disease.